Publications & Presentations

Faculty at the Center for Drug Safety have been published extensively in a wide range of publications.

2012:

Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit–acquired dysglycemia and in-hospital mortality. Crit Care Med 40(12), 2012. [epub ahead of print] doi: 10.1097/CCM.0b013e3182656ae5.

Matone M, Localio AR, Huang YS, dosReis S, Feudtner C, Rubin D. The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: A national study of US Medicaid-enrolled children. Health Services Research 47(5):1836-60, 2012. 2012. doi: 10.1111/j.1475-6773.2012.01461.x.

Gail B Rattinger; Sarah K Dutcher; Pankdeep T Chhabra; Christine S Franey; Linda Simoni-Wastila; Stephen S Gottlieb; Bruce Stuart; Ilene H Zuckerman. The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure. The American Journal of Geriatric Pharmacotherapy 2012;10(1):69-80.

Rubin,D., Matone, M., Huang, Y.S., dosReis, S., Feudtner, C., Localio, R. Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care. Children and Youth Services Review. 2012; 34: 1492-1499.

Safer DJ, Zito JM, Safer AM. Age-grouped differences in bipolar mania. Compr Psychiatry, 2012 Jun 6, [Epub ahead of print].

Behrooz Shamloo, Pankdeep Chhabra, Andrew Freedman, Arnold Potosky, Jennifer Malin, Sheila Weiss Smith. Disproportionality analysis to identify novel adverse effects of bevacizumab in the US Food and Drug Administration Adverse Event Database. Drug Safety. 2012 Jun 1;35(6):507-18 [PMID: 22612854].

Simoni-Wastila L, Qian J. Influence of prescription monitoring programs on analgesic utilization by an insured retiree population. Pharmaceopidemiology and Drug Safety. First published online: 20 September 2012; DOI: 10.1002/pds.3342.

Simoni-Wastila L. Wei YJ. Qian J. Zuckerman IH. Stuart B. Shaffer T. Dalal AA. Bryant-Comstock L. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. American Journal of Geriatric Pharmacotherapy. 10(3):201-10, 2012 Jun.

Stuart, B, Yin, X, Davidoff A, Simoni-Wastila, L, Zuckerman, I, Shoemaker, J S, & Doshi, J. Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes. Med Care, 50(11), 913-919, 2012. doi: 10.1097/MLR.0b013e31826c85f9.

Tran AR, Zito JM, Safer DJ, Hundley SM. National trends in pediatric use of anticonvulsants. Psych Services 2012 (in Advance doi 10.1176/appi.ps.201100547).

Valluri S, Zito JM, Pao M, Ballard ED, Korelitz JJ, Mattison DR, Wayne AS. Antidepressant treatment of Medicaid-insured youth with a cancer diagnosis. J Pharmaceutical Health Serv Res 2012; 3(2)109-114.

Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito JM, Shuster JJ, Olfson M. Cardiovascular safety of central nervous system stimulants in children and adolescents: Population based cohort study. BMJ, 2012 Jul 18; 345:e4627.

Zito JM. Psychotropic Medication Use in US Children and Adolescents; Key Determinants of Use and Patterns in Leading Classes. Hedgehog Review, a cultural studies academic journal, November 2012.

Zuckerman IH, Yin X, Rattinger GB, Gottlieb SS, Simoni-Wastila L, Pierce SA, Huang T-Y, Shenolikar R, Stuart B. Impact of exposure to evidence-based pharmacotherapy on outcomes following acute myocardial infarction in older adults. Journal of the American Geriatrics Society 60:1854–1861, 2012. doi: 10.1111/j.1532-5415.2012.04165.x.

2011:

Susan dosReis; Yesel Yoon; David M Rubin; Mark A Riddle; Elizabeth Noll; Aileen Rothbard Antipsychotic treatment among youth in foster care. Pediatrics 2011; 128(6):e1459-66

2008:

Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Risk of  hospitalization/emergency room visits and treatment costs associated with initial maintenance therapy of  fluticasone propionate 500mcg/salmeterol 50 mcg combination compared to ipratropium for chronic obstructive pulmonary disease in older adults. Am J Geriatr Pharmacother. 2008; 6(3):138-46.

Korelitz JJ, Zito JM, Gavin NI, et al. Asthma related medication use among children in the United States. Ann Allergy Asthma Immunol. 2008; 100:222-229.

McPherson ML, Weiss-Smith S, Powers A, Zuckerman IH. Patient's knowledge about medications is associated with diabetes control. J Res Soc Admin Pharmacy. 2008; 4:37.

Santos-Oliveira R, Smith SW, Carneiro-Leao AM. Radiopharmaceuticals drug interactions: A critical review. An Acad Bras Cienc. 2008; 80:665-675.

Simoni-Wastila L, Yang H, Lawler J. Correlates of prescription drug nonmedical use and problem use by adolescents. J Addict Med. 2008; 2:31.

Simoni-Wastila L. Increases in opioid medication use: Balancing the good with the bad. Pain. 2008; 138:245-246.

Zito JM, Derivan AT, Kratochvil CJ, Safer DJ, Fegert JM, Greenhill LL. Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child Adolesc Psychiatry Ment Health. 2008; 2:24.

Zito JM, Safer DJ, Berg LT, et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health. 2008; 2:26.

Zito JM, Safer DJ, Sai D, et al. Psychotropic medication patterns among youth in foster care. Pediatrics. 2008; 121:e157-63.

2007:

Blaisdell CJ, LoCasale R, Gu A, Weiss SR. Risk areas for pediatric acute care: Asthma differs from upper and lower respiratory illness. Health Place. 2007; 13:404-416.

Bollinger ME, Smith SW, LoCasale R, Blaisdell C. Transition to managed care impacts health care service utilization by children insured by medicaid. J Asthma. 2007; 44:717-722.

Safer DJ, Zito JM. Do antidepressants reduce suicide rates? Public Health. 2007; 121:274-277.

Smith SW. Sidelining safety--the FDA's inadequate response to the IOM. N Engl J Med. 2007; 357:960-963.

Weiss-Smith S. Pharmacoepidemiology. In: Boslaugh S, ed. Encyclopedia of Epidemiology. Sage Publication Inc. 2007.

Weiss-Smith S. The author responds. NEJM. 2007; 357:2521.

Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2007; 120:e1494-501.

Zito JM, American Society of Clinical Psychopharmacology. Pharmacoepidemiology: Recent findings and challenges for child and adolescent psychopharmacology. J Clin Psychiatry. 2007; 68:966-967.

Zito JM, Safer DJ. Is there a connection between methylphenidate and cancer in youth? Pharmacoepidemiol Drug Saf. 2007; 16:1273-1274.

2006:

Pearson SA, Soumerai S, Mah C, et al. Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Intern Med. 2006; 166:572-579.

Simoni-Wastila L., Yang H. Psychoactive Drug Abuse in Older Adults. Am J Geriatr Pharmacother. 2006; 4(4):380-394.

Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006; 44:1005-1010.

Zuckerman IH, Langenberg P, Baumgarten M, et al. Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med Care. 2006; 44:722-730.

2005:

Simoni-Wastila L., Zuckerman I.H., Singhal P., Briesacher B., Hsu V.D. National Estimates of Exposure to Prescription Drugs with Addiction Potential in Community-Dwelling Elders. Subst Abus. 2005; 26(1):33-41.